N

Nanoform Finland Oyj
OMXH:NANOFH

Watchlist Manager
Nanoform Finland Oyj
OMXH:NANOFH
Watchlist
Price: 1.128 EUR -0.35% Market Closed
Market Cap: 96.5m EUR
Have any thoughts about
Nanoform Finland Oyj?
Write Note

Intrinsic Value

NANOFH's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one NANOFH stock under the Base Case scenario is 0.761 EUR. Compared to the current market price of 1.128 EUR, Nanoform Finland Oyj is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NANOFH Intrinsic Value
0.761 EUR
Overvaluation 33%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation Backtest
Nanoform Finland Oyj

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NANOFH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NANOFH?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Nanoform Finland Oyj

Provide an overview of the primary business activities
of Nanoform Finland Oyj.

What unique competitive advantages
does Nanoform Finland Oyj hold over its rivals?

What risks and challenges
does Nanoform Finland Oyj face in the near future?

Summarize the latest earnings call
of Nanoform Finland Oyj.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nanoform Finland Oyj.

Provide P/S
for Nanoform Finland Oyj.

Provide P/E
for Nanoform Finland Oyj.

Provide P/OCF
for Nanoform Finland Oyj.

Provide P/FCFE
for Nanoform Finland Oyj.

Provide P/B
for Nanoform Finland Oyj.

Provide EV/S
for Nanoform Finland Oyj.

Provide EV/GP
for Nanoform Finland Oyj.

Provide EV/EBITDA
for Nanoform Finland Oyj.

Provide EV/EBIT
for Nanoform Finland Oyj.

Provide EV/OCF
for Nanoform Finland Oyj.

Provide EV/FCFF
for Nanoform Finland Oyj.

Provide EV/IC
for Nanoform Finland Oyj.

Show me price targets
for Nanoform Finland Oyj made by professional analysts.

What are the Revenue projections
for Nanoform Finland Oyj?

How accurate were the past Revenue estimates
for Nanoform Finland Oyj?

What are the Net Income projections
for Nanoform Finland Oyj?

How accurate were the past Net Income estimates
for Nanoform Finland Oyj?

What are the EPS projections
for Nanoform Finland Oyj?

How accurate were the past EPS estimates
for Nanoform Finland Oyj?

What are the EBIT projections
for Nanoform Finland Oyj?

How accurate were the past EBIT estimates
for Nanoform Finland Oyj?

Compare the revenue forecasts
for Nanoform Finland Oyj with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nanoform Finland Oyj and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nanoform Finland Oyj against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nanoform Finland Oyj compared to its peers.

Compare the P/E ratios
of Nanoform Finland Oyj against its peers.

Discuss the investment returns and shareholder value creation
comparing Nanoform Finland Oyj with its peers.

Analyze the financial leverage
of Nanoform Finland Oyj compared to its main competitors.

Show all profitability ratios
for Nanoform Finland Oyj.

Provide ROE
for Nanoform Finland Oyj.

Provide ROA
for Nanoform Finland Oyj.

Provide ROIC
for Nanoform Finland Oyj.

Provide ROCE
for Nanoform Finland Oyj.

Provide Gross Margin
for Nanoform Finland Oyj.

Provide Operating Margin
for Nanoform Finland Oyj.

Provide Net Margin
for Nanoform Finland Oyj.

Provide FCF Margin
for Nanoform Finland Oyj.

Show all solvency ratios
for Nanoform Finland Oyj.

Provide D/E Ratio
for Nanoform Finland Oyj.

Provide D/A Ratio
for Nanoform Finland Oyj.

Provide Interest Coverage Ratio
for Nanoform Finland Oyj.

Provide Altman Z-Score Ratio
for Nanoform Finland Oyj.

Provide Quick Ratio
for Nanoform Finland Oyj.

Provide Current Ratio
for Nanoform Finland Oyj.

Provide Cash Ratio
for Nanoform Finland Oyj.

What is the historical Revenue growth
over the last 5 years for Nanoform Finland Oyj?

What is the historical Net Income growth
over the last 5 years for Nanoform Finland Oyj?

What is the current Free Cash Flow
of Nanoform Finland Oyj?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nanoform Finland Oyj.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nanoform Finland Oyj

Current Assets 43.8m
Cash & Short-Term Investments 41.3m
Receivables 1m
Other Current Assets 1.4m
Non-Current Assets 28.5m
Long-Term Investments 1.3m
PP&E 26.4m
Intangibles 622k
Other Non-Current Assets 288k
Current Liabilities 6.6m
Accounts Payable 2m
Accrued Liabilities 2.6m
Other Current Liabilities 2.1m
Non-Current Liabilities 5m
Long-Term Debt 5m
Other Non-Current Liabilities -1k
Efficiency

Earnings Waterfall
Nanoform Finland Oyj

Revenue
2.4m EUR
Cost of Revenue
-16.4m EUR
Gross Profit
-14m EUR
Operating Expenses
-9.9m EUR
Operating Income
-23.9m EUR
Other Expenses
619.7k EUR
Net Income
-23.2m EUR

Free Cash Flow Analysis
Nanoform Finland Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In a positive earnings call, Nanoform reported increased customer signings and strengthened relationships with major pharmaceutical companies, including Takeda. The company has made significant strides in its nanoenzalutamide and nanoapalutamide projects, projecting the first Nanoformed medicine to market by 2027 in the EU and 2028 in the USA. Nanoform expects revenue growth in the second half of the year due to increased project signings and in-sourcing of GMP QC to improve margins. The company maintains a strong balance sheet with over EUR 50 million in cash and no debt.

What is Earnings Call?
Fundamental Scores

NANOFH Profitability Score
Profitability Due Diligence

Nanoform Finland Oyj's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
ROIC is Increasing
Declining ROE
22/100
Profitability
Score

Nanoform Finland Oyj's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

NANOFH Solvency Score
Solvency Due Diligence

Nanoform Finland Oyj's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Nanoform Finland Oyj's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NANOFH Price Targets Summary
Nanoform Finland Oyj

Wall Street analysts forecast NANOFH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NANOFH is 3.74 EUR with a low forecast of 3.03 EUR and a high forecast of 4.2 EUR.

Lowest
Price Target
3.03 EUR
169% Upside
Average
Price Target
3.74 EUR
232% Upside
Highest
Price Target
4.2 EUR
272% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NANOFH?

Click here to dive deeper.

Dividends

Nanoform Finland Oyj
does not pay dividends
Shareholder Yield

Current shareholder yield for NANOFH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Nanoform Finland Oyj

Country

Finland

Industry

Life Sciences Tools & Services

Market Cap

88.8m EUR

Dividend Yield

0%

Description

Nanoform Finland Oyj engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. The company is headquartered in Helsinki, Etela-Suomen and currently employs 158 full-time employees. The company went IPO on 2020-06-04. The firm is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.

Contact

ETELA-SUOMEN
Helsinki
Cultivator II, Viikinkaari 4
+358293700150
nanoform.com

IPO

2020-06-04

Employees

158

Officers

CFO & Director
Mr. Albert Alexander Haeggstrom
Co-Founder & CEO
Prof. Edward Olof Haeggstrom
Director of Investor Relations
Mr. Henri von Haartman
General Counsel & Chief Development Officer
Mr. Peter Hanninen
Head of Manufacturing
Dr. David Rowe
Chief Commercial Officer
Mr. Christian Jones
Show More
Chief of Business Operations
Mr. Antonio Da Silva
Chief Quality Officer
Ms. Johanna Kause
Vice President of Strategic Insight
Dr. Jamie Unwin
Show Less

See Also

Discover More
What is the Intrinsic Value of one NANOFH stock?

The intrinsic value of one NANOFH stock under the Base Case scenario is 0.761 EUR.

Is NANOFH stock undervalued or overvalued?

Compared to the current market price of 1.128 EUR, Nanoform Finland Oyj is Overvalued by 33%.

Back to Top